Maria R. Baer, MD, professor, department of medicine and program in oncology, was an invited speaker at the Acute Leukemia XII conference in Munich, Germany, in February 2008. She also chaired an educational session entitled “Evaluating, Treating and Supporting Older Adults with Acute Leukemia” at the 2008 American Society of Clinical Oncology annual meeting in Chicago in June 2008, and gave a talk entitled “Acute Leukemia Biology and Treatment Response in Older Adults” as part of the session.
 |
|
Thomas Blanpied, PhD
|
Thomas Blanpied, PhD, assistant professor, department of physiology, and a recent R01 National Institute of Mental Health (NIMH) grantee, was one of four new NIMH investigators invited to present research at the 218th meeting of the National Advisory Mental Health Council open policy session in Bethesda, Md., in May 2008. Blanpied's R01 (which was funded at the 0.8th percentile), is entitled “Internal Dynamics of the Postsynaptic Density.”
Brian J. Browne, MD, professor, Amal Mattu, MD, associate professor, Robert L. Rogers, MD,
 |
|
Brian Browne, MD
|
assistant professor, Michael E. Winters, MD, assistant professor, Fermin Barrueto, MD, clinical assistant professor, and Roger Stone, ’87, clinical assistant professor, all from the department of emergency medicine, were invited participants at the 14th annual scientific assembly of the American Academy of Emergency Medicine. This symposium, considered one of the premier events in emergency medicine education, was held on Amelia Island, Florida, in February 2008.
France Carrier, PhD, assistant professor, department of biochemistry & molecular biology and program in oncology, gave an invited presentation at the inaugural International Conference on Drug Design and Discovery in Dubai, United Arab Emirates, in February 2008. The title of the presentation was “Molecular Understanding of Histone Deacetylase Inhibitors (HDACIs) Efficiency in Cancer Cells.”
 |
|
France Carrier, PhD
|
 |
|
Niel Constantine, PhD
|
Rudolph J. Castellani Jr., MD, professor, department of pathology, presented “Prion Diseases in the United States” at the International Congress for Neuroprotection and Neuroplasticity in Bucharest, Romania, in March. Additionally, Castellani presented “Prion Diseases in the Baltimore, Maryland Area: A Recent Survey” at the American
Association of Neuropathologists Meeting
in San Diego in April 2008.
Niel Constantine, PhD, professor, department of pathology, was an invited speaker for the HIV Congress 2008 in Mumbai, India, in March 2008. In his presentation, “Point of Care Testing and Monitoring for HIV Infection,” Constantine informed the group of 400 participants about newer technologies appropriate for HIV identification and manual CD4 monitoring of infected persons in physician offices, public health clinics and health care facilities in remote venues. Constantine also chaired a scientific session.
 |
|
Timm-Michael Dickfeld, MD, PhD
|
 |
|
Steven Czinn, MD
|
Steven Czinn, MD, professor and chair, department of pediatrics, chaired a topic forum session, “Immunopathogenesis of H. pylori Infection,” and presented a paper entitled “Vaccine-induced Protective Immunity against Helicobacter pylori is IL-23 Dependent” at Digestive Disease Week in San Diego in May 2008.
Timm-Michael Dickfeld, MD, PhD, assistant professor, department of medicine, presented an abstract entitled “AV- Freeze: Prospective Safety Assessment of Cryo-Effects on the Human AV Node” at the meeting of the American College of Cardiology in Chicago in March 2008. This study demonstrated that unwanted effects of cryoenergy can persist in a large number of patients.
Jack Gladstein, MD, associate professor, department of pediatrics, presented a two-hour course on controversies in pediatric headaches at the American Headache Society annual meeting in Boston in June 2008.
 |
|
Jack Gladstein, MD
|
 |
|
David Mallott, MD
|
Michelle Kush, MD, assistant professor, department of obstetrics, gynecology & reproductive sciences, presented at the Food and Drug Administration spring 2008 maternal health team course. Her topic was “Drug Treatment Used in the Management of Pre-eclampsia: What is effective? What are the Standards of Care?”
David Mallott, MD, associate dean for medical education and associate professor, department of psychiatry, was an invited speaker at the Society for Inherited Metabolic Disorders 2008 annual meeting in Pacific Grove, California, in March 2008. His presentation was entitled “When Should Psychiatry Consult the Metabolic Specialist.”
Kathleen Michael, PhD, MSN, assistant professor, department of medicine, presented “Motivators for Exercise after Stroke” at the 2008 International Stroke Conference in New Orleans in February 2008.
 |
|
Alan Shuldiner, MD
|
Feyruz Rassool, PhD, associate professor, department of radiation oncology and program in oncology, was an invited speaker at a seminar series entitled “ROS, DNA Damage and Errorprone Repair: A Model for Genomic Instability in Myeloid Malignancies” in Munich, Germany, in June 2008.
Alan Shuldiner, MD, Whitehurst Professor of Medicine, and director, program in genetics and genomic medicine, presented “Pharmacogenomics of Anti-platelet Agents” at the PGRN-Riken-JSSX workshop on pharmacogenomics in Tokyo in February 2008. The purpose of the meeting was to stimulate collaboration between U.S. and Japanese scientists in the area of pharmacogenomics. He also presented “Translating Type II Diabetes and Related Traits Whole Genome Association Studies” at the National Institutes of Health’s genes, environment and health initiative symposium on translating whole genome association data into clinical practice in Bethesda, Md., in March 2008. The purpose of the meeting was for experts to review the state of the field and to identify barriers to implementing personalized medicine in the clinical setting. Additionally, Shuldiner presented “Pharmacogenomics of Antiplatelet Agents” at the international conference on pharmacogenomics, in Busan, Korea, in April 2008.
 |
|
Loren P. Thompson, PhD
|
 |
|
Sanford A. Stass, MD
|
Sanford A. Stass, MD, professor and chair, department of pathology, and interim hair, department of medical & research technology, moderated a session called “Expanding the Biomarker Pipeline” at the National Cancer Institute’s 5th annual early detection research network scientific workshop in Bethesda, Md., in March 2008.
Loren P. Thompson, PhD, associate professor, department of obstetrics, gynecology & reproductive sciences, was an invited speaker at the international conference on high risk pregnancy and fetal maternal medicine in Xian, China, in May 2008. His lecture was entitled “Impact of the Adverse Intrauterine Environment on Fetal Growth and Organ Function.”
George Wittenberg, MD, PhD, assistant professor, department of neurology, gave a presentation at the National Institute of Aging’s laboratory of cognition and personality entitled “Brain Activity in Activities of Daily Living: Practical Motor Function before and after Stroke” in Bethesda, Md., in February 2008.
|
 |
|
Michael S. Donnenberg, MD
|
 |
|
H. Moo Kwon, PhD
|
Michael S. Donnenberg, MD, professor, department of medicine, received a $1,166,667 grant from the National Institute of Allergy and Infectious Diseases to fund years 17 through 21 of his work entitled “The Eae Gene Cluster of Enteropathogenic E. coli.”
H. Moo Kwon, PhD, professor, department of medicine, received a five-year $1.6 million competitive renewal R01 grant from the National Institute of Diabetes and Digestive and Kidney Diseases for his work entitled “Tonicity Signaling to TonEBP Transcription Factor.”
Margaret M. McCarthy, PhD, professor, department of physiology, received a five-year $1,024,519 competing renewal National Institutes of Health pre-doctoral training grant from the National Institute of Neurological Disorders and Stroke for her work entitled “Training Program in Neuroscience.”
 |
|
Margaret M. McCarthy, PhD
|
 |
|
James Nataro, PhD, '87
|
James Nataro, MD, PhD, ’87, professor, department of pediatrics and center for vaccine development, received a four-year $3,414,292 grant from the National Institute of Allergy and Infectious Diseases entitled “Live Attenuated Bacterial Vaccines against Plague.” This grant will provide support for final pre-clinical development of a Salmonella-based platform technology, the ultimate intent of which is to provide protection against anthrax and plague in a single vaccine, combined with protection against typhoid fever provided by the vector itself.
Feyruz Rassool, PhD, associate professor, department of radiation oncology and program in oncology, received a three-year $1,500,000 Maryland Stem Cell Exploratory Research Grant from the Maryland Technology Development Corporation for “Dissecting the Genetics and Epigenetic Origins Underlying Tumorigenic Potential of Human Embryonic and Adult Stem Cells.”
 |
|
Edward Sausville, MD, PhD
|
 |
|
David W. Scott, PhD
|
Edward Sausville, MD, PhD, professor, department of medicine and program in oncology, received a five-year $4,000,350 K-12 Paul Calabresi Award for Clinical Oncology and a five-year $2,903,548 U01 award for “Early Clinical Trials of New Anti-Cancer Agents” from the National Cancer Institute. Sausville’s co-investigators on the last award are Martin Edelman, MD, professor, Maria Baer, MD, professor, and Ivana Gojo, MD, associate professor, all from the department of medicine.
David W. Scott, PhD, professor, departments of surgery and microbiology & immunology and center for vascular and inflammatory diseases, received a five-year $1,250,000 grant from the National Institutes of Health for his work entitled “Induction of Tolerance-Factor VIII in Hemophilic Mice.”
Grants & Contracts of $1 million and above
|